Subscribe
Today
Financial
Technology
Cyclical
Defensive
Healthcare
Energy
Industrials
Real Estate
Materials
Viewpoints
All Access Articles |
NAMS
NewAmsterdam Pharma Reports Positive Phase 3 Trial Results
| 2024-11-20 |
PHARMACEUTICAL
NewAmsterdam Pharma reports positive phase 3 trial data for obicetrapib in HeFH patients
| 2024-07-29 |
PHARMACEUTICAL
